These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28027596)

  • 21. Cost-effectiveness of combinatorial pharmacogenomic testing for depression from the Canadian public payer perspective.
    Tanner JA; Davies PE; Overall CC; Grima D; Nam J; Dechairo BM
    Pharmacogenomics; 2020 Jun; 21(8):521-531. PubMed ID: 32301648
    [No Abstract]   [Full Text] [Related]  

  • 22. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
    Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
    Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
    Roosan D; Hwang A; Roosan MR
    Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
    Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M;
    PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of Pharmacogenomics in Everyday Clinical Settings.
    Bank PCD; Swen JJ; Guchelaar HJ
    Adv Pharmacol; 2018; 83():219-246. PubMed ID: 29801576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of a pharmacogenomic program in a Brazilian public institution.
    Suarez-Kurtz G; Kovaleski G; Elias AB; Motta V; Wolch K; Emerenciano M; Mansur MB; Palladino AM; Accioly MT; Ferreira M; Gonçalves AA; de Melo AC
    Pharmacogenomics; 2020 Jun; 21(8):549-557. PubMed ID: 32378980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies.
    Rosenblat JD; Lee Y; McIntyre RS
    J Clin Psychiatry; 2017 Jun; 78(6):720-729. PubMed ID: 28068459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics in practice: a review and implementation guide.
    Kabbani D; Akika R; Wahid A; Daly AK; Cascorbi I; Zgheib NK
    Front Pharmacol; 2023; 14():1189976. PubMed ID: 37274118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
    Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
    Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QPGx-CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies.
    Abdel-Latif R; Badji R; Mohammed S; Al-Muftah W; Mbarek H; Darwish D; Assaf D; Al-Badriyeh D; Elewa H; Afifi N; Masoodi NA; Omar AS; Al Suwaidi J; Bujassoum S; Al Hail M; Ismail SI; Althani A
    Clin Transl Sci; 2024 Jun; 17(6):e13800. PubMed ID: 38818903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
    Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
    Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
    [No Abstract]   [Full Text] [Related]  

  • 36. Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementation.
    Conyers R; Halman A; Moore C; Stenta T; Felmingham B; Collier L; Khatri D; Spelman T; Williams E; Dyas R; Kotecha RS; Jessop S; Mateos MK; Swen J; Elliott DA
    BMJ Open; 2024 May; 14(5):e085115. PubMed ID: 38760050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomic testing in paediatrics: Clinical implementation strategies.
    Barker CIS; Groeneweg G; Maitland-van der Zee AH; Rieder MJ; Hawcutt DB; Hubbard TJ; Swen JJ; Carleton BC
    Br J Clin Pharmacol; 2022 Oct; 88(10):4297-4310. PubMed ID: 34907575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing pharmacogenomics decision support across seven European countries: The Ubiquitous Pharmacogenomics (U-PGx) project.
    Blagec K; Koopmann R; Crommentuijn-van Rhenen M; Holsappel I; van der Wouden CH; Konta L; Xu H; Steinberger D; Just E; Swen JJ; Guchelaar HJ; Samwald M
    J Am Med Inform Assoc; 2018 Jul; 25(7):893-898. PubMed ID: 29444243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison.
    Wake DT; Bell GC; Gregornik DB; Ho TT; Dunnenberger HM
    Pharmacogenomics; 2021 Feb; 22(3):165-176. PubMed ID: 33461326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.